|
About IFF
VENTURE CAPITALISTS
Following is an overview of the participating IFF VCs. Please click
on Firm name or logo to be directed to their respective websites.
 |
A.M. Pappas & Associates is an early to late stage
life sciences investor with offices in Indiana and North Carolina
(Research Triangle). Founded in 1994 by Art Pappas, A.M. Pappas &
Associates manages approximately $150 million in total committed
capital. The Firm's primary focus is in the biotechnology
and pharmaceutical sector, including genomics, proteomics,
medical devices, drug delivery and computational chemistry. |
 |
Burrill & Company is a life sciences merchant bank focused
exclusively on companies involved in biotechnology, pharmaceuticals,
diagnostics, devices, human healthcare and related medical
technologies, nutraceuticals and wellness, agricultural biotechnology,
and industrial biotechnology (biomaterials/bioprocesses) with
over $500 million under management. Burrill is also the sponsor
and facilitator of three leading annual industry conferences
and publishes the seminal annual report on the state of the
biotechnology industry. |
 |
Pearl Street Venture Funds ("PSVF") is an Indiana-based,
early-stage venture capital fund investing in life science
companies in the biotech, medical device, pharmaceutical and
agri-bio sectors. Pearl Street was formed as a joint venture
between Indianapolis advisory and management firm Barnard
Associates and Los Angeles-based Coastview Capital. |
 |
EDF Ventures is a leading venture capital firm investing in early-stage healthcare and information technologies. Focused on the Midwest and Southern California, our partners bring deep domain knowledge, extensive networks and a distinguished track record to every endeavor. |
 |
Spring Mill Venture Partners ("SMVP") was established
to pursue an investment strategy focused primarily on equity
securities of privately owned, emerging small businesses located
in Indiana and the surrounding region. Spring Mill was formed
by Bluespring Venture Management LLC in combination with Village
Ventures, Inc., which manages a network of 14 early-stage
funds (two in formation) located in emerging technology centers
nationwide. SMVP targets opportunities in life sciences, information
technology and other technology businesses. |
 |
Triathlon Medical Ventures Fund, L.P. is a venture capital
fund that targets investments in early-stage biomedical technology
companies located in the Midwest. The Fund also invests in
mid-to-late-stage biomedical technology companies based throughout
the U.S. The Fund's specific focus will be on high growth
sectors within biomedical technology such as medical devices,
diagnostics and biopharmaceuticals and emerging fields such
as genomics, proteomics, regenerative medicine and drug discovery. |
|
|
